OCRL inositol polyphosphate-5-phosphatase
Last updated 13 Apr 2026
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The OCRL gene provides instructions for making the enzyme OCRL, which is present in cells throughout the body. OCRL is part of a larger group of enzymes that modify fat (lipid) molecules known as membrane phospholipids. Phospholipids help form the basic structure of cell membranes.
Video picks for GenesVideo library
Normal function
The OCRL gene provides instructions for making the enzyme OCRL, which is present in cells throughout the body. OCRL is part of a larger group of enzymes that modify fat (lipid) molecules known as membrane phospholipids. Phospholipids help form the basic structure of cell membranes.
OCRL is found in several areas within cells. It is concentrated in a complex network of membranes known as the trans-Golgi network, which sorts proteins and other molecules and sends them to their proper locations. OCRL is also found in endosomes, specialized compartments that help transport proteins and other molecules within the cell. The trans-Golgi network and endosomes play an important role in endocytosis, which is the process of transporting proteins from the outer cell membrane to the inside of the cell.
Endocytosis is especially important in proximal tubular cells. Proximal tubules are structures that are found in the kidneys. They help reabsorb proteins and other nutrients into the bloodstream. OCRL plays a key role in the kidneys' ability to reabsorb proteins and important nutrients.
Recent research suggests that OCRL is also involved in the formation of certain types of cilia. Cilia are microscopic, finger-like projections that stick out from the surface of cells. They are important for the structure and function of many types of cells, including cells in the eyes and kidneys.
Conditions referring to this gene or chromosome
Other names
Dent disease 2
Dent-2
OCRL1
Patient picks for Genes

PCOS Q&A
How do sufferers of PCOS ovulate?
Dr Sarah Jarvis MBE If you have no periods, or very infrequent periods, you may have a higher-than-average risk of developing cancer of the womb (uterus). However, the evidence for this is not conclusive and, if there is a risk, it is probably small and can be prevented. [https://patient.info/health/polycystic-ovary-syndrome-leaflet#nav-5](https://patient.info/health/polycystic-ovary-syndrome-leaflet#nav-5)
by Dr Sarah Jarvis

Periods - late and missed
What does weight have to do with missed periods?
Dr Sarah Jarvis MBE Meet with a dietician to create a plan for gaining weight. If you're missing your period due to a low body weight, talk with your GP and dietician about healthy ways to put on weight. Excess body fat can cause your periods to become irregular. Meet with your GP or practice nurse, who may be able to refer you to a dietician to discuss ways to lose weight. Even losing 5% of your body fat can help get your cycles back on track. This can be particularly helpful if you're dealing with PCOS. [https://patient.info/health/periods-and-period-problems/features/missed-period-irregular-period-reasons](https://patient.info/health/periods-and-period-problems/features/missed-period-irregular-period-reasons)
by Dr Sarah Jarvis

STI
How do I get tested for HIV/AIDS?
Dr Rosemary Leonard Most sexual health clinics offer a rapid blood test for HIV and can give results within thirty minutes. Even if rapid testing is not available, the results are usually back within a week. Modern tests will pick up the infection a month after first being infected (as opposed to three months with the older tests). GPs can also arrange blood tests. The result will go on your health record but negative results are no longer considered important by organisations such as insurance and loan companies. It is recommended that all men who have sex with men should be tested every year. [https://patient.info/health/sexually-transmitted-infections-leaflet/hiv-and-aids#nav-5](https://patient.info/health/sexually-transmitted-infections-leaflet/hiv-and-aids#nav-5)
by Dr Rosemary Leonard MBE, MRCGP

Allergies
How do hay fever tablets work?
Dr Sarah Jarvis MBE If your hay fever symptoms are not controlled on the medication that you are taking after 2-4 weeks, you should discuss this with your doctor. You may need to try a different treatment or add in another treatment. If you are taking hay fever medication regularly and your hay fever is well controlled on your current treatment, you should continue this treatment until the end of the pollen season. [https://patient.info/health/hay-fever-leaflet#nav-5](https://patient.info/health/hay-fever-leaflet#nav-5)
by Dr Sarah Jarvis

Breast cancer
How often is breast cancer misdiagnosed?
Dr Sarah Jarvis MBE Finding out the stage of the cancer, the grade of the cells and the receptor status of the cancer helps doctors to advise on the best treatment options. It also gives a reasonable indication of outlook. [https://patient.info/health/breast-cancer-leaflet#nav-5](https://patient.info/health/breast-cancer-leaflet#nav-5)
by Dr Sarah Jarvis

Allergies
How many hay fever tablets can I take in a day?
Dr Sarah Jarvis MBE There are several types and brands of antihistamines that you can buy at pharmacies or get on prescription. Older antihistamines, such as chlorphenamine, work well but make some people drowsy. So, they should not be taken if you are driving or operating machinery. There are several newer ones that cause less drowsiness. Ask your pharmacist or doctor for advice. [https://patient.info/health/hay-fever-leaflet#nav-5](https://patient.info/health/hay-fever-leaflet#nav-5)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Peripheral vasodilators
Peripheral vasodilators are medicines that are used to treat conditions that affect blood vessels in outer (peripheral) parts of the body such as the arms and legs. Inositol nicotinate and pentoxifylline are not considered effective for PAD. Cilostazol Cilostazol tablets and inositol nicotinate work by widening the arteries that supply blood to.

Patient information leaflet
Chronic kidney disease
Severity can vary but most cases are mild or moderate, occur in older people and do not cause symptoms. Chronic kidney disease (CKD) means that the kidneys are not working as well as they used to, either due to being diseased or damaged in some way, or due to ageing. Chronic means ongoing, persistent and long-term. The word "failure" implies that.

Patient information leaflet
Diet in chronic kidney disease
Chronic kidney disease (CKD) is a common long-term condition where the kidneys aren't working as well as they should be. There are some dietary choices that are recommended for people with early CKD. See the separate Healthy Eating Healthy eating leaflet for more information. If your kidney function is becoming worse (stage 4 to 5), you will.

Patient information leaflet
Polycystic kidney disease
Polycystic kidney disease (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys. The most common type of PKD is an inherited condition called autosomal dominant polycystic kidney disease (ADPKD). What is polycystic kidney disease. A cyst is a fluid-filled sac. Cysts occur in various sizes, in various conditions and in various parts.

Patient information leaflet
Testicular cancer
Testicular cancer is a cancer that arises from a testicle (testis). Around half of all cases occur in men aged under 35 but testicular cancer rarely occurs before puberty. Another useful test i... The tumour markers commonly tested for are alpha-fetoprotein (AFP), beta human chorionic gonadotrophin (beta-hCG), lactic dehydrogenase (LDH) and.

Patient information leaflet
Kawasaki disease
Kawasaki disease is a rare condition that affects small to medium-sized blood vessels in the body. Kawasaki disease causes the the walls of the blood vessels to become inflamed and swollen (vasculitis). Kawasaki disease mainly affects children less than 5 years old. The exact cause of Kawasaki disease remains unknown. Kawasaki disease causes a.
Further reading and references
- OCRL inositol polyphosphate-5-phosphatase; MedlinePlus, National Library of Medicine.
- Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature. 1992 Jul 16;358(6383):239-42. doi: 10.1038/358239a0.
- Choudhury R, Diao A, Zhang F, Eisenberg E, Saint-Pol A, Williams C, Konstantakopoulos A, Lucocq J, Johannes L, Rabouille C, Greene LE, Lowe M. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell. 2005 Aug;16(8):3467-79. doi: 10.1091/mbc.e05-02-0120. Epub 2005 May 25.
- Claverie-Martin F, Ramos-Trujillo E, Garcia-Nieto V. Dent's disease: clinical features and molecular basis. Pediatr Nephrol. 2011 May;26(5):693-704. doi: 10.1007/s00467-010-1657-0. Epub 2010 Oct 10.
- Coon BG, Hernandez V, Madhivanan K, Mukherjee D, Hanna CB, Barinaga-Rementeria Ramirez I, Lowe M, Beales PL, Aguilar RC. The Lowe syndrome protein OCRL1 is involved in primary cilia assembly. Hum Mol Genet. 2012 Apr 15;21(8):1835-47. doi: 10.1093/hmg/ddr615. Epub 2012 Jan 6.
- Ehlayel AM, Copelovitch L. Update on Dent Disease. Pediatr Clin North Am. 2019 Feb;66(1):169-178. doi: 10.1016/j.pcl.2018.09.003.
- Erdmann KS, Mao Y, McCrea HJ, Zoncu R, Lee S, Paradise S, Modregger J, Biemesderfer D, Toomre D, De Camilli P. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell. 2007 Sep;13(3):377-90. doi: 10.1016/j.devcel.2007.08.004.
- Hall AM, Polesel M, Berquez M. The proximal tubule, protein uptake, and the riddle of the segments. Kidney Int. 2021 Apr;99(4):803-805. doi: 10.1016/j.kint.2020.12.031.
- Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, Baujat G, Blanchard A, Nobili F, Ranchin B, Remesy M, Salomon R, Satre V, Lunardi J. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2011 Apr;32(4):379-88. doi: 10.1002/humu.21391. Epub 2011 Mar 10.
- Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ. Dent Disease with mutations in OCRL1. Am J Hum Genet. 2005 Feb;76(2):260-7. doi: 10.1086/427887. Epub 2004 Dec 30.
- Hyvola N, Diao A, McKenzie E, Skippen A, Cockcroft S, Lowe M. Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases. EMBO J. 2006 Aug 23;25(16):3750-61. doi: 10.1038/sj.emboj.7601274. Epub 2006 Aug 10.
- Jin YY, Huang LM, Quan XF, Mao JH. Dent disease: classification, heterogeneity and diagnosis. World J Pediatr. 2021 Feb;17(1):52-57. doi: 10.1007/s12519-020-00357-1. Epub 2020 Apr 4.
- Lewis RA, Nussbaum RL, Brewer ED. Lowe Syndrome. 2001 Jul 24 [updated 2019 Apr 18]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1480/
- Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E. Dent Disease. 2012 Aug 9 [updated 2017 Dec 14]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK99494/
- Lowe M. Structure and function of the Lowe syndrome protein OCRL1. Traffic. 2005 Sep;6(9):711-9. doi: 10.1111/j.1600-0854.2005.00311.x.
- Luo N, West CC, Murga-Zamalloa CA, Sun L, Anderson RM, Wells CD, Weinreb RN, Travers JB, Khanna H, Sun Y. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome. Hum Mol Genet. 2012 Aug 1;21(15):3333-44. doi: 10.1093/hmg/dds163. Epub 2012 Apr 27.
- McCrea HJ, Paradise S, Tomasini L, Addis M, Melis MA, De Matteis MA, De Camilli P. All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding. Biochem Biophys Res Commun. 2008 May 2;369(2):493-9. doi: 10.1016/j.bbrc.2008.02.067. Epub 2008 Feb 26.
- Pirruccello M, De Camilli P. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem Sci. 2012 Apr;37(4):134-43. doi: 10.1016/j.tibs.2012.01.002. Epub 2012 Feb 28.
- Raucher D, Stauffer T, Chen W, Shen K, Guo S, York JD, Sheetz MP, Meyer T. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell. 2000 Jan 21;100(2):221-8. doi: 10.1016/s0092-8674(00)81560-3.
- Saito A, Sato H, Iino N, Takeda T. Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium. J Biomed Biotechnol. 2010;2010:403272. doi: 10.1155/2010/403272.
- Utsch B, Bokenkamp A, Benz MR, Besbas N, Dotsch J, Franke I, Frund S, Gok F, Hoppe B, Karle S, Kuwertz-Broking E, Laube G, Neb M, Nuutinen M, Ozaltin F, Rascher W, Ring T, Tasic V, van Wijk JA, Ludwig M. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis. 2006 Dec;48(6):942.e1-14. doi: 10.1053/j.ajkd.2006.08.018.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

